An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity
CARDIOCARE is proud to announce that Prof. Giuseppe Curigliano, MD, PhD, Scientific Manager of CARDIOCARE, was appointed as the President of the European Society for Medical Oncology (ESMO) for 2027-2028. Also, Prof. Curigliano will take seat on the ESMO Executive Board as of 1 January 2025.
More details on this appointment can be found here.
Highlights
We are pleased to announce that our challenge proposal, “EchoRisk-MICCAI: AI for Cardiac Function Estimation, Assessment & Early Prediction of Therapy-Induced Cardiotoxicity from Echocardiography” (Proposal ID: 234), has been officially accepted as a Satellite...
On 16 February 2026, the CARDIOCARE webinar entitled “CARDIOCARE: digital and imaging strategies for cardiovascular and QoL monitoring in breast cancer patients” was successfully delivered, attracting 309 participants (of the 538 registered) from across Europe and...
The second podcast of CARDIOCARE entitled "Cardiotoxicity & Multi-Source Information" is available on the YouTube channel of the project. In this podcast, Professor D. Fotiadis and Professor K. Naka from the University of Ioannina (Greece) explore the...